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Background: In theory, heat shock protein (HSP70) can reduce the expression 
of Cyt. C, Bax, and Caspase 3, in apoptosis ofmultiple organ dysfunction 
syndrome (MODS), and thereby can prevent death. Previous researchers used 
226 g/KgBW/intraperitoneal (ip) of HSP70. There is a lack of studies which 
used the lowest effective dose of HSP70. This study aimed to determine the 
lowest effective dose of HSP70 to prevent death in sepsis mice model with MODS. 
Subjects and Method: This was a randomized control trial conducted at PAU 
Universitas GadjahMada, Yogyakarta, from April 1 to 21, 2017. The study subjects 
were Balbs/c strain mice. The drug used to induce death was Lipopolysaccharides 
(LPS) from SIGMA L2880-10MG Lot #025M4040V from Escherichia coli 055:B5 
purified by phenol extraction.The drug used to prevent death in this study was 
Rat Heat Shock Protein (HSP70) Lot#L16020515. A sample of 25 mice was 
randomized into 5 groups with each consisting of 5 mice: (1) control group with 
NaCl; (2) experimental group receiving LPS injection of 0.25mg/kgBW/ip; (3) 
experimental group receiving LPS injection of 0.25mg/kgBW/ip with HSP70 
injection of 100 µg/kgBW/ip; (4) experimental group receiving LPS injection of 
0.25mg/KgBW/ip with HSP70 injection of 200 µg/kgBW/ip; and (5) 
experimental group receiving LPS injection of 0.25mg/kgBW/ip with HSP70 
injection of 300 µg/kgBW/ip. The percent of live mice between groups was 
compared by chi square.  
Results: Three days after intervention, the number of live mice 13(86.7%) in the 
experimental group with ≥100 µg/kgBW/ip HSP70 was greater than the number 
of live mice 2 (40%) in the experimental group with <100 µg/kgBW/ip HSP70, 
with p= 0.037. In addition, all mice receiving ≥200µg/kgBW/ip HSP70 in the 
experimental group were alive three days after intervention. 
Conclusion: The lowest effective dose of HSP70 to prevent death in sepsis mice 
model with MODS is 100µg/kgBW/ip. All mice are alive three days after receiving 
≥200µg/kgBW/ip HSP70.  
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